SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001132413-08-000076
Filing Date
2008-05-09
Accepted
2008-05-08 21:51:00
Documents
1
Group Members
COGNIZANT HOLDINGS, LTD.INTEGRATED HOLDING GROUP LPISRAEL A. ENGLANDERMILLENNIUM INTERNATIONAL MANAGEMENT GP LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLCMILLENNIUM PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 alxn_sc13d-a2.htm SC 13D/A 7155265
  Complete submission text file 0001132413-08-000076.txt   7157717
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Subject) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-47771 | Film No.: 08815824
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O MILLENNIUM MANAGEMENT, L.L.C. 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT, L.L.C. 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100
MILLENCO, L.L.C. (Filed by) CIK: 0001132413 (see all company filings)

IRS No.: 133532932 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A